Allogene Therapeutics Inc (ALLO)

11:06 AM

Allogene Therapeutics (ALLO) Impacted by Patent Dispute Involving Cellectis - GuruFocus

11:06 AM

10:25 AM

Allogene licensor Cellectis faces patent case (ALLO:NASDAQ) - Seeking Alpha

10:25 AM

06:57 AM

What to do if you’re stuck in Allogene Therapeutics Inc.2025 Macro Impact & Free Safe Entry Trade Signal Reports - newser.com

06:57 AM

06:05 AM

Allogene Therapeutics Faces Potential Patent Infringement Issues - TradingView

06:05 AM

05:59 AM

Using portfolio simulators with Allogene Therapeutics Inc. includedMarket Risk Analysis & Low Risk Investment Opportunities - newser.com

05:59 AM

Oct 13, 2025

Chart based analysis of Allogene Therapeutics Inc. trendsWeekly Stock Analysis & Weekly Top Gainers Trade List - newser.com

Oct 13, 2025

Oct 10, 2025

What’s the recovery path for long term holders of Allogene Therapeutics Inc.July 2025 Review & Reliable Momentum Entry Alerts - newser.com

Oct 10, 2025

Oct 10, 2025

Published on: 2025-10-10 09:33:16 - newser.com

Oct 10, 2025

Oct 10, 2025

Applying sector rotation models to Allogene Therapeutics Inc.July 2025 Decliners & Weekly High Potential Stock Alerts - newser.com

Oct 10, 2025

Oct 10, 2025

This Keysight Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga

Oct 10, 2025

Oct 10, 2025

Is Allogene Therapeutics Inc. stock poised for growth2025 Price Targets & Technical Pattern Based Buy Signals - newser.com

Oct 10, 2025

Oct 10, 2025

Allogene, Pliant down as J.P. Morgan cuts to Underweight on uncertain outlook - Seeking Alpha

Oct 10, 2025

Oct 10, 2025

JP Morgan Downgrades Allogene Therapeutics (ALLO) to Underweight - GuruFocus

Oct 10, 2025

Oct 10, 2025

JPMorgan Downgrades Allogene Therapeutics to Underweight From Neutral - MarketScreener

Oct 10, 2025

Oct 10, 2025

What technical models suggest about Allogene Therapeutics Inc.’s comebackWeekly Profit Recap & Weekly Breakout Watchlists - newser.com

Oct 10, 2025

Oct 09, 2025

Allogene Therapeutics Inc. stock volume spike explainedMarket Growth Report & Real-Time Volume Analysis - newser.com

Oct 09, 2025

Oct 08, 2025

Allogene Therapeutics' (ALLO) Sell (E+) Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 08, 2025

Oct 08, 2025

What analysts say about Allogene Therapeutics Inc stockFundamental Stock Analysis & Free Triple Digit Wealth Increase - earlytimes.in

Oct 08, 2025

Oct 06, 2025

Allogene's Q2 Loss Narrower Than Expected, Pipeline in Focus - MSN

Oct 06, 2025

Oct 06, 2025

Measuring Allogene Therapeutics Inc.’s beta against major indicesCEO Change & Consistent Profit Trade Alerts - newser.com

Oct 06, 2025

Oct 06, 2025

What does recent volatility data suggest for Allogene Therapeutics Inc.Portfolio Risk Report & Weekly Chart Analysis and Guides - newser.com

Oct 06, 2025

Oct 05, 2025

What indicators show strength in Allogene Therapeutics Inc.Weekly Profit Report & Fast Moving Market Watchlists - newser.com

Oct 05, 2025

Oct 05, 2025

Market reaction to Allogene Therapeutics Inc.’s recent newsMarket Weekly Review & AI Driven Price Predictions - newser.com

Oct 05, 2025

Oct 05, 2025

Published on: 2025-10-05 03:06:55 - newser.com

Oct 05, 2025

Oct 04, 2025

Allogene Therapeutics (NASDAQ:ALLO) Rating Increased to Hold at Wall Street Zen - MarketBeat

Oct 04, 2025

Oct 03, 2025

Allogene Therapeutics at Citi’s SMID Call Series: Strategic Insights By Investing.com - Investing.com Canada

Oct 03, 2025

Oct 03, 2025

Published on: 2025-10-03 05:33:11 - newser.com

Oct 03, 2025

Oct 02, 2025

Applying big data sentiment scoring on Allogene Therapeutics Inc.Short Setup & Capital Efficient Trade Techniques - newser.com

Oct 02, 2025

Oct 02, 2025

Published on: 2025-10-02 20:30:24 - newser.com

Oct 02, 2025

Oct 01, 2025

Published on: 2025-10-01 08:38:29 - newser.com

Oct 01, 2025

Oct 01, 2025

Analyzing net buyer seller activity in Allogene Therapeutics Inc.July 2025 Review & Daily Technical Forecast Reports - newser.com

Oct 01, 2025

Sep 30, 2025

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Sep 30, 2025

Sep 29, 2025

Published on: 2025-09-29 14:28:46 - newser.com

Sep 29, 2025

Sep 29, 2025

Published on: 2025-09-29 11:38:34 - newser.com

Sep 29, 2025

Sep 29, 2025

Published on: 2025-09-29 07:57:40 - newser.com

Sep 29, 2025

Sep 26, 2025

Will Allogene Therapeutics Inc. stock beat EPS estimatesJuly 2025 Selloffs & Smart Allocation Stock Reports - The British Mountaineering Council

Sep 26, 2025

Sep 22, 2025

344,880 Shares in Allogene Therapeutics, Inc. $ALLO Purchased by Kingstone Capital Partners Texas LLC - MarketBeat

Sep 22, 2025

Sep 21, 2025

Real time scanner hits for Allogene Therapeutics Inc. explained2025 Technical Overview & Weekly High Return Forecasts - newser.com

Sep 21, 2025

Sep 20, 2025

Profit Recap: Can Allogene Therapeutics Inc. be the next market leaderPortfolio Performance Summary & AI Forecasted Stock Moves - khodrobank.com

Sep 20, 2025

Sep 20, 2025

Will Allogene Therapeutics Inc stock hit new highs in YEAR2025 Fundamental Recap & Reliable Breakout Forecasts - khodrobank.com

Sep 20, 2025

Sep 19, 2025

Custom watchlist performance reports with Allogene Therapeutics Inc.Insider Selling & Weekly Return Optimization Plans - newser.com

Sep 19, 2025

Sep 18, 2025

Update Report: Will Allogene Therapeutics Inc benefit from geopolitical trends2025 Market Sentiment & AI Driven Price Predictions - khodrobank.com

Sep 18, 2025

Sep 18, 2025

Allogene Therapeutics (NASDAQ:ALLO) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat

Sep 18, 2025